Advancing Innovation to the Market.
XPI supports entrepreneurs, early-stage technology companies, and tech transfer offices — providing strategic guidance, managerial resources, and capital, to bring breakthrough technologies to market.
TRACK RECODER
100
+
technology-based companies our principals have worked with
Digital health · Medical device · Advanced materials · Climate tech · Transportation · Energy · Industrial systems · Software (patented algorithms)
ABOUT US
A sounding board and an implementation catalyst.
XPI's principals have worked with over 100 technology-based companies, supporting technology and product development, licensing, fundraising, business development, and M&A transactions.
We bring an independent, objective perspective paired with a bias toward action—helping our partners define what matters, develop clear strategies, and execute through critical inflection points.
Our approach is hands-on and outcome-driven. We work alongside founders and teams to align strategy, resources, and capital, with a focus on maximizing the commercial potential of their technologies and intellectual property.
e X perience
Deep practical knowledge gained through interaction with, or observation of, people, events, and facts.
P erspicacity
Having keen mental perception, sharp insight, and the ability to understand complex situations quickly and accurately.
I mpact
A powerful and highly-beneficial contribution.
WHAT WE DO
Support entrepreneurs and early-stage technology companies in designing and implementing their plans for success.
Value Creation Services
We partner with technology-based early-stage companies to serve as hands-on strategic partners and execution collaborators. We focus on guidance and support in:
-
Startup creation and securing funding
-
Technology licensing and development
-
Product development
-
Business development
-
M&A and strategic partnerships
VentureMax™
We partner with early-stage technology companies (Corporate Partners) to fund, develop, and commercialize their technologies and intellectual property in areas the Corporate Partners are not pursuing as they focus their resources on their core applications and markets.
The partnership is created through the establishment of a Newco into which the Corporate Partner licenses its technology and IP in certain fields of use, and XPI contributes financial and managerial resources. The Corporate Partner receives equity in Newco, access to new IP, and an option to purchase Newco.
PORTFOLIO
Companies we have partner with.
A selection of the entrepreneurs and technology teams we are supporting through Value Creation Services — providing hands-on guidance across funding strategy, IP commercialization, and business development.
Ossentia Medical, Inc.
Medical Device
2024
Advanced orthopedic anchors for optimal bone fixation.
Ossentia has developed a unique bone anchor based on controlled-expansion fixation technology that leverages both physical expansion and osteointegration to enhance fixation strength. Designed to address key limitations of current orthopedic anchors, this enhanced fixation technology has the potential to reduce surgical failures and the need for revision procedures.
XPI ENGAGEMENT
Early-stage funding support | Strategic guidance regarding commercialization pathway | IP and positioning strategy | Coordination and management of relationships with regulatory consultants, external testing laboratories, and clinical advisors.
CARA Systems, Inc.
Health Tech
2025
Clinical decision intelligence for neurovascular care.
CARA has developed AneuView™, a clinical decision intelligence engine for precision neurovascular care. AneuView™ integrates imaging, hemodynamic, and clinical data to deliver interpretable aneurysm rupture-risk assessment at the point of care, helping reduce radiologist workload, improve clinical decision-making, and triage and monitoring for the millions of people living with brain aneurysms.
XPI ENGAGEMENT
Early-stage funding support | Development of strategic partnerships with leading medical centers and clinical institutions | Go-to-market and commercialization strategy.
FAQS
Common questions.
CONTACT US
Let's start a conversation.
If you're an entrepreneur or a technology-based company looking to unlock untapped applications and markets — reach out.
.jpg)

